Search

everythinglearnresearchcommunity

for

Search:↓

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

LGR5 mainly stays inside cells, moving to the trans-Golgi network, and this process is important for its role in cell signaling.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

A new, efficient method was developed to synthesize a specific compound and its derivatives.

Dracorhodin perchlorate helps heal wounds in diabetic rats by reducing inflammation.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

A 532 nm laser at 15 J/cm2 speeds up tendon healing by increasing tendon stem cell growth and tendon-related gene activity.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Exosomes from hair papilla cells and the Chinese medicine Liao Tuo Fang can potentially promote hair growth and could be used to develop hair growth drugs.

A feedback loop between LRH and RSL4 controls root hair growth in Arabidopsis.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

A 940nm laser effectively reduces inflammation in rat joints.

Activating TRPV3 stops human hair growth.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

A new treatment for hair loss shows promise with fewer side effects.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

The new gel improves skin delivery of a drug, potentially reducing dose frequency and side effects.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

MR antagonists may improve skin health and wound healing, especially in aging.